July 2020 FDA Recall Drug by Golden State Medical Supply Inc.
D-1497-2020 - Failed Content Uniformity
This Class III drug recall was voluntarily initiated by Golden State Medical Supply Inc. on July 24, 2020 for the product Drug. The FDA reported the reason for recall as failed content uniformity. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-1497-2020
Failed Content Uniformity: bulk lot used to make these two lots was found to have failed content uniformity.
07-24-2020
08-19-2020
N/A
Recall Profile & Regulatory Data
Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Golden State Medical Supply Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Nationwide within the United States
12-10-2020
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Clobetasol Propionate Cream, USP, 0.05%, packaged in a)15g Tubes (NDC 60429-902-15) and b) 45g Tubes (NDC 60429-902-45), Rx Only, Mfd. by: Taro Pharmaceuticals Inc. Brampton, Ontario, Canada, Marketed by: Golden State Medical Supply Inc. Camarillo, CA 93012.
Batch or Lot Expiration Information
Lot# : a) AB28535, Exp. Date: Dec. 2021 b) AB40178, Exp. Date: Dec. 2021